Impact of Atogepant on Migraine Day Reduction, Responder Rate, and Patient-Reported Outcomes in Participants with Chronic Migraine and Moderate to Severe Symptoms of Depression as Measured by Patient Health Questionnaire-9

Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/57134

Title:	Impact of Atogepant on Migraine Day Reduction, Responder Rate, and Patient-Reported Outcomes in Participants with Chronic Migraine and Moderate to Severe Symptoms of Depression as Measured by Patient Health Questionnaire-9
Authors:	ASHINA, S.; GANDHI, P.; DABRUZZO, B.; LIU, Y.; SEMINERIO, M.; STOKES, J.; SENG-TAMACCIO, E.; BUSE, D.; PERES, M.; LIPTON, R.; POZO-ROSICH, P.
Citation:	HEADACHE, v.63, suppl.1, Special Issue, p.61-62, 2023
Appears in Collections:	Comunicações em Eventos - HC/IPq Instituto de Psiquiatria - HC/IPq Comunicações em Eventos - LIM/21 LIM/21 - Laboratório de Neuroimagem em Psiquiatria

Files in This Item:

There are no files associated with this item.